Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
129.78
+2.00 (1.57%)
At close: Mar 13, 2026, 4:00 PM EDT
128.05
-1.73 (-1.33%)
After-hours: Mar 13, 2026, 5:41 PM EDT
Neurocrine Biosciences Analyst Ratings
Total Analysts
22
Consensus Rating
Strong Buy
Price Target
$175.27
Upside
+35.05%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $176 → $177 | Buy | Maintains | $176 → $177 | +36.38% | Mar 12, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $160 | Buy | Initiates | $160 | +23.29% | Feb 24, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $177 → $176 | Buy | Maintains | $177 → $176 | +35.61% | Feb 17, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $169 → $140 | Strong Buy | Maintains | $169 → $140 | +7.87% | Feb 17, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $180 → $175 | Buy | Maintains | $180 → $175 | +34.84% | Feb 13, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $203 → $204 | Strong Buy | Maintains | $203 → $204 | +57.19% | Feb 12, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $180 → $177 | Buy | Maintains | $180 → $177 | +36.38% | Feb 12, 2026 |
| BMO Capital | BMO Capital | Hold Maintains $147 → $140 | Hold | Maintains | $147 → $140 | +7.87% | Feb 12, 2026 |
| Wedbush | Wedbush | Buy Maintains $149 → $151 | Buy | Maintains | $149 → $151 | +16.35% | Feb 12, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $198 → $192 | Strong Buy | Maintains | $198 → $192 | +47.94% | Feb 12, 2026 |
| Needham | Needham | Strong Buy Maintains $187 → $185 | Strong Buy | Maintains | $187 → $185 | +42.55% | Feb 12, 2026 |
| UBS | UBS | Strong Buy Maintains $188 → $178 | Strong Buy | Maintains | $188 → $178 | +37.16% | Jan 23, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $179 → $177 | Buy | Maintains | $179 → $177 | +36.38% | Jan 12, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $172 → $169 | Strong Buy | Maintains | $172 → $169 | +30.22% | Jan 8, 2026 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $173 → $175 | Buy → Hold | Downgrades | $173 → $175 | +34.84% | Jan 8, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $168 → $198 | Strong Buy | Maintains | $168 → $198 | +52.57% | Dec 17, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.